Clinical Efficacy of Different Fissure Sealant Materials in the Newly Erupted Non-Carious First Permanent Molars
Launched by IZMIR KATIP CELEBI UNIVERSITY · Apr 18, 2021
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
Firstly, patients were randomly allocated to three main groups: Group 1; Fuji II LC/Fuji Triage (Control) (62 patients), Group 2; Clinpro XT Varnish/Fuji Triage (Control) (60 patients), Group 3; Beautifil Flow/Fuji Triage (Control) (60 patients). After clinical applications, all samples were evaluated in terms of retention, marginal adaptation, marginal discoloration and secondary caries formation using modified USPHS criteria in 6th, 12th and 18th months. Also samples were evaluated in terms of remineralization effect using the laser fluorescence method. Evaluations on occlusal and buccal ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children who have two newly erupted non-carious mandibular permanent first molars that fissure sealant is indicated,
- • Newly erupted first permanent molars show scores of 0 (Sound tooth surface)-1(First visual change in enamel) according to ICDAS II,
- • Newly erupted first permanent molars show scores between 0-13 by using DIAGNOdent device,
- • Children who haven't any systemic disease that prevents the application,
- • Cooperative children who allowed the clinical applications.
- Exclusion Criteria:
- • Teeth with proximal and initial caries,
- • Teeth with applied fissure sealant,
- • Teeth with developmental defects such as hypoplasia and restorations,
- • Non-cooperative children who don't allow the clinical applications,
- • Children and parents who denied the participation in the follow-up appointments.
About Izmir Katip Celebi University
Izmir Katip Celebi University is a prominent academic institution in Turkey, dedicated to advancing medical research and education. The university is committed to fostering innovation and excellence in clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of experienced researchers and healthcare professionals. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Izmir Katip Celebi University actively engages in collaborative research initiatives, aiming to address critical health challenges through rigorous scientific inquiry and ethical practices in clinical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Izmir, , Turkey
Patients applied
Trial Officials
Merve Akcay, assoc. prof.
Study Chair
Izmir Katip Celebi Uni
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials